Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle

Microbes and Infection

Volumn 3, Issue 9, 2001, Pages 763-770

  Matovu, Enock ^a,b   Seebeck, Thomas ^b   Enyaru, John C K ^a   Kaminsky, Ronald ^c  

^a Livestock Health Research Institute Uganda   (Uganda)

^b Institute of Cell Biology   (Switzerland)

^c Centre de Recherche Sante Animale   (Switzerland)

Author keywords

African trypanosomosis; Drug resistance; Sleeping sickness; Trypanosoma brucei

Indexed keywords

ABC TRANSPORTER; ADENOSINE; DIMINAZENE; EFLORNITHINE; ISOMETAMIDIUM; ISOMETAMIDIUM CHLORIDE; MELARSOPROL; PENTAMIDINE; TRYPARSAMIDE; VERAPAMIL;

AFRICA SOUTH OF THE SAHARA; AFRICAN TRYPANOSOMIASIS; ANIMAL PARASITOSIS; CATTLE; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; HOST; MICROBIAL GENETICS; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOTIDE TRANSPORT; PARASITE VECTOR; PRIORITY JOURNAL; REVIEW; TRYPANOSOMA BRUCEI; TRYPANOSOMA GAMBIENSE; TRYPANOSOMA RHODESIENSE;

EID: 0034904388     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(01)01432-0     Document Type: Review

References (53)

1. Berenil resistant Trypanosoma vivax, isolated from naturally infected cattle in Teso district, Eastern Uganda
2. The appearance of isometamidium resistant Trypanosoma congolense in west Africa
3. Multiple drug resistance in Trypanosoma vivax in the Tana River district of Kenya
4. Berenil (Diminazene aceturate) resistant Trypanosoma congolense in cattle under natural tsetse challenge at Kibaha, Tanzania
5. Efficacy of trypanocidal compounds against multiple resistant Trypanosoma brucei brucei stock in mice
6. Therapeutic effect of Berenil and Samorin in mice infected with four trypanosome populations isolated from Zambian cattle
7. Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomosis in Uganda
8. Sensitivity of animal-derived Trypanozoon stocks from sleeping sickness endemic foci of Nigeria to trypanocides and human plasma
9. Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya
10. Clinical Mel B resistance in Rhodesian sleeping sickness
11. Susceptibility of Ugandan Trypanosoma brucei rhodesiense isolated from man and animal reservoirs to diminazene, isometamidium and melarsoprol
12. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-α-difluoromethylornithine (DFMO)
13. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness
14. Drug management and parasite resistance in bovine trypanosomosis in Africa
15. Role of antibody in the elimination of trypanosomes after DL-α-difluoromethylornithine chemotherapy
16. Cyclization and N dealkylation of chloroguanide by rabbit and rat hepatic microsomes
17. Genetic exchange in Trypanosoma brucei: Selection of hybrid trypanosomes by introduction of genes conferring drug resistance
18. Hybrid formation between African trypanosomes during cyclical transmission
19. Sexual compatibility among Trypanosoma brucei isolates from an epidemic area in south-eastern Uganda
20. Pharmacokinetic properties of the trypanocidal drug malarsoprol
21. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: A randomised trial
22. Pharmacokinetic and histopathological investigations of isometamidium in cattle
23. Pharmacokinetics of diminazene in plasma and cerebrospinal fluid of goats
24. The brain as a source of relapsing Trypanosoma brucei infections in mice after chemotherapy
25. Validating targets for antiparasite chemotherapy
26. The mechanism of drug resistance in Trypanosoma brucei spp.
27. Synergism between 9-deazainosine and DL-α-difluoromethylornithine in treatment of experimental African trypanosomosis
28. Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-α-difluoromethylornithine and standard trypanocides
29. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-α-difluoromethylornithine), an inhibitor of the ornithine decarboxylase; first field trial
30. Differential susceptibility to DL-α-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense
31. Resistance to DL-α-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense: Role of s-adenosylmethionine
32. Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to DL-α-difluoromethylornithine
33. Amplification of the inosinate dehydrogenase gene in Trypanosoma brucei gambiense due to an increase in chromosome copy number
34. Transport of isometamidium (Samorin) by drug resistant and drug sensitive Trypanosoma congolense
35. Alterations in drug transport in resistant Trypanosoma congolense
36. Studies in chemotherapy V: Preliminary contribution on the nature of drug resistance
37. Flow cytofluorimetric analysis of drug accumulation by multi-drug-resistant Trypanosoma brucei brucei and T. b. rhodesiense
38. Uptake of diamidine drugs by P2 nucleoside transporter in melarsen-sensitive and resistant Trypanosoma brucei brucei
39. Characterisation of pentamidine-resistant Trypanosoma brucei brucei
40. A Trypanosoma brucei mutant resistant to difluoromethylornithine
41. Uptake of difluoromethylornithine by Trypanosoma brucei brucei
42. The preparation of a strain of Trypanosoma rhodesiense resistant to stilbamidine and some observations on its nature
43. Multiple drug resistance in the pathogenic protozoa
44. Energy dependence of chloroquine accumulation and chloroquine efflux in plasmodium falciparum
45. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil
46. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand
47. Mechanisms of drug resistance in Leishmania
48. Increase in mRNA of multiple Eh pgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites
49. Identification of three ABC transporter genes in Trypanosoma brucei spp
50. The effect of verapamil alone and in combination with trypanocides on multi-drug-resistant Trypanosoma brucei brucei
51. Arsenical resistant trypanosomes lack an unusual adenosine transporter
52. A diamidine with reduced substrate affinity
53. A nucleoside transporter from Trypanosoma brucei involved in drug resistance